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Certain investigations showed that genetic factors of 
bronchial asthma (BA) and obesity overlap each other, this indicates 
that they have common genetic predisposition. Thus, BA and obesity 
are associated with the genes, which encode β-adrenergic receptor, 
insulin-like growth factor, IL-1α, leukotriene A4 hydroxylase, 
glucocorticoid receptor (GR), uncoupling protein, etc. 
The objective of this investigation was to analyze possible 
association between BclI polymorphism of GR gene and obesity 
among patients with BA. 
Materials and methods. 188 patients with BA have been 
examined. The control group consisted of 95 apparently healthy adult 
individuals. We measured body mass, height, body mass index 
(BMI).  The determination of allelic polymorphism in the second 
exon of the GR gene, Bcl1 (C647G) - rs41423247, was performed by 
polymerase chain reaction (by Fleury I. еt al.) with modifications.  
Results. Among patients with BA, normal body mass (NBM) 
was found in 50.5% of individuals, overweight - 15.4%, obesity- 
34%. In the control group, 76.8% of the investigated had NBM, 20% 
had overweight and 3.2% had obesity. It has been demonstrated that 
obesity occurs more often among BA patients, than in the control 
group. The patients with BA had higher BMI parameter, than the 
individuals in the control group (27.2+0.44 kg/m
2
 VS. 23.5=0.29 
kg/m
2; P<0.001). The obtained data showed that BMI values didn‘t 
significantly differ in carriers with different genotypes for BclI 
polymorphism in the control group (P=0.9126). However, 
dependence between BclI polymorphism and BMI parameters was 
found among patients with BA: G/G genotype carriers had higher 
BMI (31.3=0.74 kg/m
2
).  
Genotypes distribution for BclI polymorphism among 
patients with BA showed a statistically significant difference 
between patients with different BMI unlike the control group. G/G 
homozygotes had higher BMI, than those in the control group or with 
other genotypes. BMI didn‘t much differ between C/C and C/G 
genotypes carriers. 
 
